Associate Director, Scientific Publications

Who We Are

Xenon Pharmaceuticals (NASDAQ:

XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life‑changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.

We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late‑stage clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b X‑TOLE study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic‑clonic seizures.

In November 2025, we announced the completion of patient enrollment in our Phase 3 X‑TOLE2 study, and topline data are anticipated in March 2026. We also have multiple Phase 3 azetukalner clinical trials in major depressive disorder (MDD) and bipolar depression (BPD) underway, based on topline data from our Phase 2 X‑NOVA clinical trial. In addition, we are proud of the leading‑edge science coming out of our discovery labs, including early‑stage research programs that leverage our extensive ion channel expertise and drug discovery capabilities to identify validated drug targets and develop new product candidates.

We have recently initiated Phase 1 studies for our follow‑on Kv7 channel opener, XEN
1120, and our lead Nav
1.7 development candidate, XEN
1701, in pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.

We are seeking a Associate Director, Scientific Publications to take a hands‑on role in shaping, driving, and executing publications for Xenon’s clinical‑stage programs. This role combines strategic thinking with operational excellence to ensure timely, high‑quality, and compliant publications across congresses and journals. The incumbent will support publication planning, govern relationships with external agencies, provide day‑to‑day oversight of records within our publication management system, collaborate closely with authors and reviewers, and provide additional contributions to the Scientific Communications team as necessary.

This position reports to the Director of Scientific Publications and involves forging close relationships with colleagues within Medical Affairs, Regulatory, Legal/Compliance, Value and Access, and Corporate Communications.

This role will be based out of Boston, MA, USA in our Needham office. We will consider remote locations for exceptional candidates. Hybrid positions require a minimum of two onsite days per week. On‑site positions require up to five on‑site days per week.

• Contribute to the design, refinement, and execution of integrated publication plans that align with Xenon’s development milestones, evidence needs, and competitive landscape.
• Apply program knowledge, core scientific messages, and lexicon foundations to ensure consistency across manuscripts, abstracts, posters, presentations, and publication extenders.
• Maintain a strong command of therapeutic landscapes, study designs, emerging data, and evolving evidence needs to ensure publication plans stay relevant and responsive.
• Integrate cross‑functional insights and help shape scientific publication priorities in alignment with small biopharmaceutical agility and resource considerations.
• Drive the execution of abstracts, posters, oral presentations, manuscripts, reviews, and plain language summaries from concept through submission and publication.
• Ensure all content adheres to GPP/ICMJE guidelines, company SOPs, and industry expectations for scientific integrity, authorship, transparency, and documentation.
• Guide relationships with vendors and freelance partners by…